Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients.
about
Adeno-associated virus-mediated cancer gene therapy: current statusNovel delivery approaches for cancer therapeutics.Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsAdeno-associated virus (AAV) vectors in cancer gene therapy.Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.Modern strategies and capabilities for activation of the immune response against tumor cells.
P2860
Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical safety of induced CTL ...... on in Chinese cancer patients.
@en
type
label
Clinical safety of induced CTL ...... on in Chinese cancer patients.
@en
prefLabel
Clinical safety of induced CTL ...... on in Chinese cancer patients.
@en
P2093
P2860
P1476
Clinical safety of induced CTL ...... on in Chinese cancer patients.
@en
P2093
Chunrong Zhang
Fengling Wan
Gonghong Song
Huabing Yang
P2860
P2888
P304
P356
10.1007/S12094-012-0854-7
P577
2012-07-19T00:00:00Z